NasdaqCM - Delayed Quote USD
Psyence Biomedical Ltd. (PBMWW)
At close: 4:00 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Operating Cash Flow
-2,945.3670
-2,945.3670
-1,592.0800
-1,396.4220
Investing Cash Flow
-5.7270
-5.7270
--
-32.0395
Financing Cash Flow
2,350.0000
2,350.0000
1,172.9230
-1,627.5764
End Cash Position
733.1880
733.1880
1,334.2800
1,755.0382
Capital Expenditure
-5.7270
-5.7270
--
--
Issuance of Debt
2,500.0000
2,500.0000
--
--
Repayment of Debt
-150.0000
-150.0000
--
--
Free Cash Flow
-2,951.0940
-2,951.0940
-1,592.0800
-1,396.4220
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DWTX Dogwood Therapeutics, Inc.
4.1100
+4.05%
LIPO Lipella Pharmaceuticals Inc.
0.4760
-2.78%
CYCC Cyclacel Pharmaceuticals, Inc.
1.4300
+8.33%
NRXBF NUREXONE BIOLOGIC INC
0.4000
+2.56%
NKGNW NKGen Biotech, Inc.
0.0379
-7.56%
OKUR OnKure Therapeutics, Inc.
18.83
+1.51%
SLXN Silexion Therapeutics Corp
0.4499
+33.94%
MDXXF Pharmala Biotech Holdings Inc.
0.1276
-8.86%
CDT Conduit Pharmaceuticals Inc.
0.1132
+6.59%
NWRN.SW Newron Pharmaceuticals S.p.A.
9.00
+0.45%